Literature DB >> 16769912

Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.

Paul A Friedman1, Robyn L McClelland, William R Bamlet, Helbert Acosta, David Kessler, Thomas M Munger, Neal G Kavesh, Mark Wood, Emile Daoud, Ali Massumi, Claudio Schuger, Stephen Shorofsky, Bruce Wilkoff, Michael Glikson.   

Abstract

BACKGROUND: Delivery of inappropriate shocks caused by misdetection of supraventricular tachycardia (SVT) remains a substantial complication of implanted cardioverter/defibrillator (ICD) therapy. Whether use of optimally programmed dual-chamber ICDs lowers this risk compared with that in single-chamber ICDs is not clear. METHODS AND
RESULTS: Subjects with a clinical indication for ICD (n=400) at 27 participating centers received dual-chamber ICDs and were randomly assigned to strictly defined optimal single- or dual-chamber detection in a single-blind manner. Programming minimized ventricular pacing. The primary end point was the proportion of SVT episodes inappropriately detected from the time of programming until crossover or end of study. On a per-episode basis, 42% of the episodes in the single-chamber arm and 69% of the episodes in the dual-chamber arm were due to SVT. Mortality (3.5% in both groups) and early study withdrawal (14% single-chamber, 11% dual-chamber) were similar in both groups. The rate of inappropriate detection of SVT was 39.5% in the single-chamber detection arm compared with 30.9% in the dual-chamber arm. The odds of inappropriate detection were decreased by almost half with the use of the dual-chamber detection enhancements (odds ratio, 0.53; 95% confidence interval, 0.30 to 0.94; P=0.03).
CONCLUSIONS: Dual-chamber ICDs, programmed to optimize detection enhancements and to minimize ventricular pacing, significantly decrease inappropriate detection.

Entities:  

Mesh:

Year:  2006        PMID: 16769912     DOI: 10.1161/CIRCULATIONAHA.105.594531

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  45 in total

Review 1.  Strategic choices to reduce implantable cardioverter-defibrillator-related morbidity.

Authors:  Oussama Wazni; Bruce L Wilkoff
Journal:  Nat Rev Cardiol       Date:  2010-04-20       Impact factor: 32.419

2.  Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study.

Authors:  Jörg Otto Schwab; Hendrik Bonnemeier; Thomas Kleemann; Johannes Brachmann; Sven Fischer; Frank Birkenhauer; Frank Eberhardt
Journal:  Clin Res Cardiol       Date:  2015-05-23       Impact factor: 5.460

Review 3.  Troubleshooting implantable cardioverter-defibrillators: an overview for physicians who are not electrophysiologists.

Authors:  Mohammad Saeed
Journal:  Tex Heart Inst J       Date:  2011

4.  Impaired left atrial function predicts inappropriate shocks in primary prevention implantable cardioverter-defibrillator candidates.

Authors:  Susumu Tao; Hiroshi Ashikaga; Luisa A Ciuffo; Kihei Yoneyama; Joao A C Lima; Terry F Frank; Robert G Weiss; Gordon F Tomaselli; Katherine C Wu
Journal:  J Cardiovasc Electrophysiol       Date:  2017-06-22

5.  Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.

Authors:  Mina K Chung; Steven J Szymkiewicz; Mingyuan Shao; Edwin Zishiri; Mark J Niebauer; Bruce D Lindsay; Patrick J Tchou
Journal:  J Am Coll Cardiol       Date:  2010-07-13       Impact factor: 24.094

6.  Multicenter automatic defibrillator implantation trial: reduce inappropriate therapy (MADIT-RIT): background, rationale, and clinical protocol.

Authors:  Claudio Schuger; James P Daubert; Mary W Brown; David Cannom; N A Mark Estes; W Jackson Hall; Torsten Kayser; Helmut Klein; Brian Olshansky; Keith A Power; David Wilber; Wojciech Zareba; Arthur J Moss
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-07       Impact factor: 1.468

7.  Effect of supplemented intake of omega-3 fatty acids on arrhythmias in patients with ICD: fish oil therapy may reduce ventricular arrhythmia.

Authors:  Dalit Weisman; Roy Beinart; Aharon Erez; Nira Koren-Morag; Ilan Goldenberg; Michael Eldar; Michael Glikson; David Luria
Journal:  J Interv Card Electrophysiol       Date:  2017-06-29       Impact factor: 1.900

Review 8.  ICD programming.

Authors:  Mauro Biffi
Journal:  Indian Heart J       Date:  2013-12-20

9.  Determinants of inappropriate implantable cardioverter-defibrillator shocks: the German Device Registry perspective.

Authors:  Erdal Safak; Lars Eckardt; Werner Jung; Hüseyin Ince; Jochen Senges; Matthias Hochadel; Christian Perings; Stefan Spitzer; Johannes Brachmann; Karlheinz Seidl; Hans Ulrich Hink; Giuseppe D'Ancona
Journal:  J Interv Card Electrophysiol       Date:  2019-08-02       Impact factor: 1.900

10.  Optimal Programming of ICDs for Prevention of Appropriate and Inappropriate Shocks.

Authors:  Ronald Lo; Amin Al-Ahmad; Henry Hsia; Paul C Zei; Paul J Wang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.